Found 25 matching trials
A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19 PHASE2 New outpatient treatments for COVID-19 are urgently needed. There is some e...
Show More Location
Robert Wood Johnson Medical School
Learn More & Join Trial
PROLIFIC ChemoprophylaxisTrial (COVID-19) PHASE3 The number of confirmed cases of COVID-19 infectious disease arising from t...
Show More Location
Cambridge University Hospitals NHS Foundation Trust
Learn More & Join Trial
AIPH-TB: AI-Optimised Pyrazinamide-Hydroxychloroquine vs Standard RIPE for Drug-Sensitive Pulmonary Tuberculosis - A Phase II RCT PHASE2 Tuberculosis (TB) kills 1.3 million people annually and remains the world's...
Show More Location
Riyadh First Health Cluster, Ministry of Health
Learn More & Join Trial
Will Hydroxychloroquine Impede or Prevent COVID-19 PHASE3 This is a prospective, multi-site study designed to evaluate whether the us...
Show More Location
Henry Ford Hospital
Learn More & Join Trial
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia PHASE3 REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform tria...
Show More Location
University of Florida
Learn More & Join Trial
Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant Melanoma PHASE1 This phase 1/2 trial addresses the efficacy and safety of the combination o...
Show More Learn More & Join Trial
To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613ยฎ (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue PHASE1 The goal of this trial in Phase I is to determine the maximally tolerated d...
Show More Learn More & Join Trial
Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore PHASE2 Given the high prevalence of COVID19 illness (both SARS-CoV-2 RT-PCR confir...
Show More Location
Montefiore Medical Center
Learn More & Join Trial
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease PHASE3 Hydroxychloroquine (HCQ) is a systemic lupus erythematosus (SLE) medication...
Show More Location
University of California, Los Angeles
Learn More & Join Trial
Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO) PHASE1 This research study is being done to learn what effect 12 months of treatme...
Show More Location
University of Michigan
Learn More & Join Trial